EXONATE LIMITED
About
Exonate is a biotechnology company developing novel, non-invasive, small-molecule therapeutics for patients with retinal vascular diseases which may lead to vision loss. Our lead asset, EXN407, has the potential to be the first topical treatment for retinal vascular diseases, including diabetic retinopathy and diabetic macular oedema. The asset met all endpoints and displayed encouraging signals of efficacy in diabetic patients with retinal eye disease (diabetic macular oedema) in a Phase Ib/IIa trial.
GB
WTL Moorfield Road, Duxford, Cambridgeshire
CB22 4PS
Privately Held
16
Pharmaceutical Manufacturing
Top Decision Makers · 3
Senior Scientist
Susan Liddell
United Kingdom
******@***.com
Phone
(**) *** ****
Senior Scientist
Claire Allen
United Kingdom
******@***.com
Phone
(**) *** ****
Head of Biology
Kenneth McKechnie
United Kingdom
******@***.com
Phone
(**) *** ****
Find the Right Leads
Find Verified Contact Data
What LeadContact does well
Find verified emails, phone numbers, and decision-makers with 98% accuracy.
Find Leads
Find the right people by company, role, industry, location, and more.
925M+ professional profiles
Find Emails
Access verified email addresses for your target contacts.
657M+ emails
Find Phone Numbers
Get cross-validated phone data from multiple top sources.
239M+ phone numbers
More Accurate. Lower Cost.
Find contact data in 1 tool with 98% accuracy
LeadContact integrates leading enrichment tools to deliver more accurate contact data—without paying for each one.
Great conversations start with the right contact.
It’s time to find yours.